Aslan, MehmetCıtlak, Hilal KarabağTopal, ErdemBag, Harika G. GozukaraKaplan, Fatih2024-08-042024-08-0420232149-52542458-8849https://doi.org/10.21673/anadoluklin.1288549https://search.trdizin.gov.tr/yayin/detay/1199247https://hdl.handle.net/11616/88465Aim: This study aimed to determine the effect of adding nebulized magnesium sulfate to standard treatment in children with moderate to severe acute asthma attacks. Methods: Pediatric patients admitted to the emergency department with moderate to severe asthma attacks were included in the study. The patients were divided into two groups. Group S received standard treatment, while Group M received nebulized magnesium sulfate in addition to standard therapy. Results: A total of 129 patients were included in the study, 86 (66.7%) were male, and the median (minimum-maximum) age was 4 (2-8) years. When groups were compared, oxygen saturation at hour 1 was higher (p=0.024), and the PRAM (preschool respiratory assessment measure) scores at the 4th hour were lower (p=0.008) in the group that received magnesium sulfate. The groups had no differences regarding any of the other parameters at the 1st and 4th hours (p>0.05). Conclusion: Adding nebulized magnesium sulfate to standard treatment in children with asthma attacks improves oxygen saturation faster and positively affects PRAM score at hour 4.eninfo:eu-repo/semantics/openAccessArticle28325926510.21673/anadoluklin.12885491199247